For the quarter ending 2026-01-31, PURE has $788K in assets. $7,061K in debts. $198K in cash and cash equivalents.
| Balance Sheets | 2026-01-31 | 2025-10-31 | 2025-07-31 | |
|---|---|---|---|---|
| Cash and cash equivalents | 198 | 434 | 334 | |
| Accounts receivable | 252 | 389 | 474 | |
| Inventories, net | 244 | 237 | 141 | |
| Restricted cash | 75 | 75 | 75 | |
| Prepaid expenses | 10 | 41 | 23 | |
| Total current assets | 779 | 1,176 | 1,047 | |
| Property, plant and equipment, net | 9 | 10 | 11 | |
| Total assets | 788 | 1,186 | 1,058 | |
| Accounts payable | 767 | 879 | 784 | |
| Convertible notes payable to related parties, current | 2,139 | 2,104 | - | |
| Accrued liabilities | 149 | 176 | 154 | |
| Total current liabilities | 3,055 | 3,159 | 938 | |
| Convertible notes payable to related parties, non-current | 4,006 | 3,573 | 5,236 | |
| Total liabilities | 7,061 | 6,732 | 6,174 | |
| Common stock, 0.01 par value 200,000,000 shares authorized, 111,886,473 shares issued and outstanding at january 31, 2026, and july 31, 2025 | 1,119 | 1,119 | 1,119 | |
| Additional paid-in capital | 132,851 | 132,793 | 132,759 | |
| Accumulated deficit | -140,243 | -139,458 | -138,994 | |
| Total stockholders deficiency | -6,273 | -5,546 | -5,116 | |
| Total liabilities and stockholders deficiency | 788 | 1,186 | 1,058 | |
PURE BIOSCIENCE, INC. (PURE)
PURE BIOSCIENCE, INC. (PURE)